Zoll Medical Signs Definite Agreement To Buy Itamar Medical For $538M
The combination of Zoll Medical and Itamar Medical would help strengthen the collaboration between the worlds of cardiology and sleep medicine, Jon Rennert, Zoll’s CEO said.
You may also be interested in...
IV BioHoldings CEO Marty Keiser connects data, technology, capital and people to create start-ups focusing on liquid biopsy programs.
A pilot study of the augmented reality system suggests it improves the precision of knee arthroplasty surgery.
Caresyntax raised $130m in total funding to expand commercialization of its software that seeks to reduce variability and improve outcomes in the operating room.